Johnson & Johnson reported a 4.9 percent year-on-year increase in Q2 sales to $1,241 million for its Vision business unit, which includes both contact lenses and surgery activities. In constant currencies, revenue went up by 10.9 percent versus Q2 2021.
Buying a membership today will give you:
To continue reading this article register now.